Acquisition of Phillips-Medisize Corporation completed
The previously announced acquisition of Phillips-Medisize Corporation has been completed by Molex. Phillips-Medisize, a portfolio company of Golden Gate Capital, will operate as an indirect subsidiary of Molex, LLC. Financial terms of the transaction have not been disclosed.
“Phillips-Medisize brings strong capabilities to Molex in the medical solutions market globally,” said Martin Slark, Chief Executive Officer of Molex, LLC. “Combining Molex’s expertise in electronics and our broad manufacturing presence with Phillips-Medisize’s talented and experienced team will help us better serve the growing needs of the global market for innovative connected health solutions.”
Matt Jennings, Chairman, President and Chief Executive Officer, Phillips-Medisize Corporation, said: "Phillips-Medisize is excited to be joining the Molex team and looks forward to the opportunities ahead.”
Jennings added: “Phillips-Medisize and Molex together create a strong alignment for continued growth in the connected health solutions market, while maintaining focus on quality, service and innovation.”
Featured products
MAX17793
Analog Devices Inc.
3V to 80V, 3A, High-Efficiency, Synchronous Step-Down DC-DC Converter
| SKU: | MAX17793 |
|---|---|
| Stock: | 9316 |
| Cost: | $3.64 |
MAX22516
Analog Devices Inc.
IO-Link Data Link Controller with Transceiver and Integrated DC-DC
| SKU: | MAX22516 |
|---|---|
| Stock: | 8000 |
| Cost: | $5.42 |
